US2985589A
(en)
|
1957-05-22 |
1961-05-23 |
Universal Oil Prod Co |
Continuous sorption process employing fixed bed of sorbent and moving inlets and outlets
|
US3832460A
(en)
|
1971-03-19 |
1974-08-27 |
C Kosti |
Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
|
US4140755A
(en)
|
1976-02-13 |
1979-02-20 |
Hoffmann-La Roche Inc. |
Sustained release tablet formulations
|
DE3036390A1
(de)
|
1980-09-26 |
1982-05-13 |
Troponwerke GmbH & Co KG, 5000 Köln |
Neue pyrrolo-pyrimidine, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von biologischen wirkstoffen
|
DE3220113A1
(de)
|
1982-05-28 |
1983-12-01 |
Basf Ag, 6700 Ludwigshafen |
Difluormethoxiphenylthiophosphorsaeureester
|
US4402832A
(en)
|
1982-08-12 |
1983-09-06 |
Uop Inc. |
High efficiency continuous separation process
|
US4548990A
(en)
|
1983-08-15 |
1985-10-22 |
Ciba-Geigy Corporation |
Crosslinked, porous polymers for controlled drug delivery
|
US4498991A
(en)
|
1984-06-18 |
1985-02-12 |
Uop Inc. |
Serial flow continuous separation process
|
NL8403224A
(nl)
|
1984-10-24 |
1986-05-16 |
Oce Andeno Bv |
Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
|
CA1306260C
(en)
|
1985-10-18 |
1992-08-11 |
Shionogi & Co., Ltd. |
Condensed imidazopyridine derivatives
|
US5702688A
(en)
*
|
1986-12-23 |
1997-12-30 |
Tristrata Technology, Inc. |
Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
|
JP2541702B2
(ja)
|
1989-10-11 |
1996-10-09 |
帝人株式会社 |
二環性ピリミジン誘導体、その製造方法およびそれを有効成分とする医薬製剤
|
IT1258781B
(it)
|
1992-01-16 |
1996-02-29 |
Zambon Spa |
Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
AU671491B2
(en)
|
1992-12-18 |
1996-08-29 |
F. Hoffmann-La Roche Ag |
N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
|
JPH0710876A
(ja)
|
1993-06-24 |
1995-01-13 |
Teijin Ltd |
4位に環状アミノ基を有するピロロ[2,3―d]ピリミジン
|
EP0727217A3
(en)
|
1995-02-10 |
1997-01-15 |
Suntory Ltd |
Pharmaceutical and cosmetic compositions containing God-type ellagitannin as an active ingredient
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
EP0836602B1
(en)
|
1995-07-05 |
2002-01-30 |
E.I. Du Pont De Nemours And Company |
Fungicidal pyrimidinones
|
US5630943A
(en)
|
1995-11-30 |
1997-05-20 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Discontinuous countercurrent chromatographic process and apparatus
|
GB9604361D0
(en)
|
1996-02-29 |
1996-05-01 |
Pharmacia Spa |
4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors
|
JP2000504023A
(ja)
|
1996-04-03 |
2000-04-04 |
メルク エンド カンパニー インコーポレーテッド |
癌治療方法
|
WO1997038664A2
(en)
|
1996-04-18 |
1997-10-23 |
Merck & Co., Inc. |
A method of treating cancer
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
EP0934270A1
(en)
|
1996-05-30 |
1999-08-11 |
Merck & Co., Inc. |
A method of treating cancer
|
US6624138B1
(en)
|
2001-09-27 |
2003-09-23 |
Gp Medical |
Drug-loaded biological material chemically treated with genipin
|
JP2001524079A
(ja)
|
1997-04-07 |
2001-11-27 |
メルク エンド カンパニー インコーポレーテッド |
ガンの治療方法
|
US6060038A
(en)
|
1997-05-15 |
2000-05-09 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
US6063284A
(en)
|
1997-05-15 |
2000-05-16 |
Em Industries, Inc. |
Single column closed-loop recycling with periodic intra-profile injection
|
CA2295620A1
(en)
|
1997-08-11 |
1999-02-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
5,6-heteroaryl-dipyrido¬2,3-b:3',2'-f|azepines and their use in the prevention or treatment of hiv infection
|
US6075056A
(en)
*
|
1997-10-03 |
2000-06-13 |
Penederm, Inc. |
Antifungal/steroid topical compositions
|
US6025366A
(en)
|
1998-04-02 |
2000-02-15 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
PL345906A1
(en)
|
1998-06-04 |
2002-01-14 |
Abbott Lab |
Cell adhesion-inhibiting antinflammatory compounds
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
ATE459616T1
(de)
|
1998-08-11 |
2010-03-15 |
Novartis Ag |
Isochinoline derivate mit angiogenesis-hemmender wirkung
|
JP2000119271A
(ja)
|
1998-08-12 |
2000-04-25 |
Hokuriku Seiyaku Co Ltd |
1h―イミダゾピリジン誘導体
|
EP1109534B1
(en)
|
1998-09-10 |
2003-02-12 |
Nycomed Danmark A/S |
Quick release pharmaceutical compositions of drug substances
|
FR2785196B1
(fr)
|
1998-10-29 |
2000-12-15 |
Inst Francais Du Petrole |
Procede et dispositif de separation avec des zones chromatographiques a longueur variable
|
US6413419B1
(en)
|
1998-10-29 |
2002-07-02 |
Institut Francais Du Petrole |
Process and device for separation with variable-length chromatographic
|
US6375839B1
(en)
|
1998-10-29 |
2002-04-23 |
Institut Francais Du Petrole |
Process and device for separation with variable-length chromatographic zones
|
US6333384B1
(en)
|
1998-11-02 |
2001-12-25 |
Gil Technologies |
Vinyl-terminated polybutadiene and butadiene-styrene copolymers containing urethane and/or ester residues, and the electrical laminates obtained therefrom
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
JP2002538121A
(ja)
|
1999-03-03 |
2002-11-12 |
メルク エンド カムパニー インコーポレーテッド |
プレニルタンパク質トランスフェラーゼの阻害剤
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
WO2000063168A1
(en)
|
1999-04-16 |
2000-10-26 |
Coelacanth Chemical Corporation |
Synthesis of azetidine derivatives
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
DE60013464T2
(de)
|
1999-10-13 |
2005-09-15 |
Banyu Pharmaceutical Co., Ltd. |
Substituierte imidazolin-derivate
|
EP1382339B1
(en)
|
1999-12-10 |
2007-12-05 |
Pfizer Products Inc. |
Compositions containing pyrrolo ¬2,3-d pyrimidine derivatives
|
EP1263759B1
(en)
|
1999-12-24 |
2010-09-08 |
Aventis Pharma Limited |
Azaindoles
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
PT1142566E
(pt)
|
2000-04-07 |
2004-02-27 |
Medidom Lab |
Formulacao oftalmica topica na forma de uma solucao aquosa e uso de uma ciclosporina em associacao com acido hialuronico ou um de seus sais e com polisorbato 80
|
AU4878601A
(en)
|
2000-04-20 |
2001-11-07 |
Mitsubishi Corporation |
Aromatic amide compounds
|
EP1278748B1
(en)
|
2000-04-25 |
2011-03-23 |
ICOS Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
US7498304B2
(en)
|
2000-06-16 |
2009-03-03 |
Curis, Inc. |
Angiogenesis-modulating compositions and uses
|
AU2001275495B2
(en)
|
2000-06-16 |
2006-08-17 |
Curis, Inc. |
Angiogenesis-modulating compositions and uses
|
US6335342B1
(en)
|
2000-06-19 |
2002-01-01 |
Pharmacia & Upjohn S.P.A. |
Azaindole derivatives, process for their preparation, and their use as antitumor agents
|
US6930115B2
(en)
|
2000-06-23 |
2005-08-16 |
Mitsubishi Pharma Corporation |
Antitumor effect potentiators
|
CN100351253C
(zh)
|
2000-06-26 |
2007-11-28 |
辉瑞产品公司 |
作为免疫抑制剂的吡咯并[2,3-d]嘧啶化合物
|
CA2413330A1
(en)
|
2000-06-28 |
2002-01-03 |
Smithkline Beecham P.L.C. |
Wet milling process
|
MXPA03005001A
(es)
|
2000-12-05 |
2003-09-05 |
Vertex Pharma |
Inhibidores de n- terminal c-jun cinasas (jnk) y otras proteinas cinasas.
|
GB0100622D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds V111
|
JP2004520347A
(ja)
|
2001-01-15 |
2004-07-08 |
グラクソ グループ リミテッド |
Ldl−受容体発現のインデューサーとしてのアリールピペリジンおよびピペラジン誘導体
|
CA2436487A1
(en)
|
2001-01-30 |
2002-08-08 |
Cytopia Pty Ltd. |
Methods of inhibiting kinases
|
WO2002092573A2
(en)
|
2001-05-16 |
2002-11-21 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
|
US7301023B2
(en)
|
2001-05-31 |
2007-11-27 |
Pfizer Inc. |
Chiral salt resolution
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
EP1414443B1
(en)
|
2001-08-01 |
2006-11-15 |
Merck & Co., Inc. |
BENZIMIDAZO 4,5-f|ISOQUINOLINONE DERIVATIVES
|
JP4456365B2
(ja)
|
2001-09-19 |
2010-04-28 |
アベンティス・ファーマ・ソシエテ・アノニム |
化合物
|
US6429231B1
(en)
|
2001-09-24 |
2002-08-06 |
Bradley Pharmaceuticals, Inc. |
Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
|
WO2003037347A1
(en)
|
2001-10-30 |
2003-05-08 |
Novartis Ag |
Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
|
JP2003155285A
(ja)
|
2001-11-19 |
2003-05-27 |
Toray Ind Inc |
環状含窒素誘導体
|
EP1460059A4
(en)
|
2001-11-30 |
2005-01-05 |
Teijin Ltd |
PROCESS FOR PRODUCING 5- (3-CYANOPHENYL) -3-FORMYLBENZOIC ACID COMPOUND
|
GT200200234A
(es)
|
2001-12-06 |
2003-06-27 |
|
Compuestos cristalinos novedosos
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
WO2003091246A1
(en)
|
2002-04-26 |
2003-11-06 |
Vertex Pharmaceuticals Incorporated |
Pyrrole derivatives as inhibitors of erk2 and uses thereof
|
WO2003092595A2
(en)
|
2002-05-02 |
2003-11-13 |
Merck & Co., Inc |
Tyrosine kinase inhibitors
|
CN1658836A
(zh)
|
2002-05-07 |
2005-08-24 |
控制传输系统公司 |
形成药物传递装置的方法
|
US7122550B2
(en)
|
2002-05-23 |
2006-10-17 |
Cytopia Pty Ltd |
Protein kinase inhibitors
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
US7385018B2
(en)
|
2002-06-26 |
2008-06-10 |
Idemitsu Kosan Co., Ltd. |
Hydrogenated copolymer, process for producing the same, and hot-melt adhesive composition containing the same
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
GB0215844D0
(en)
|
2002-07-09 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
JPWO2004007472A1
(ja)
|
2002-07-10 |
2005-11-17 |
小野薬品工業株式会社 |
Ccr4アンタゴニストおよびその医薬用途
|
JP2006502183A
(ja)
|
2002-09-20 |
2006-01-19 |
アルコン,インコーポレイテッド |
ドライアイ障害の処置のためのサイトカイン合成インヒビターの使用
|
US20040204404A1
(en)
|
2002-09-30 |
2004-10-14 |
Robert Zelle |
Human N-type calcium channel blockers
|
WO2004041814A1
(en)
|
2002-11-04 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyramidine derivatives as jak inhibitors
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
US20040099204A1
(en)
|
2002-11-25 |
2004-05-27 |
Nestor John J. |
Sheet, page, line, position marker
|
JP2006509000A
(ja)
|
2002-11-26 |
2006-03-16 |
ファイザー・プロダクツ・インク |
移植片拒絶反応の処置の方法
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
UY28126A1
(es)
|
2002-12-24 |
2004-06-30 |
Alcon Inc |
Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular
|
US7135493B2
(en)
|
2003-01-13 |
2006-11-14 |
Astellas Pharma Inc. |
HDAC inhibitor
|
US7167750B2
(en)
|
2003-02-03 |
2007-01-23 |
Enteromedics, Inc. |
Obesity treatment with electrically induced vagal down regulation
|
JP2006518381A
(ja)
|
2003-02-07 |
2006-08-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なヘテロアリール置換ピロール
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
EP1615906A1
(en)
|
2003-04-03 |
2006-01-18 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
SE0301373D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
SE0301372D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
FR2857454B1
(fr)
|
2003-07-08 |
2006-08-11 |
Aventis Pasteur |
Dosage des acides techoiques des bacteries gram+
|
US20050043346A1
(en)
|
2003-08-08 |
2005-02-24 |
Pharmacia Italia S.P.A. |
Pyridylpyrrole derivatives active as kinase inhibitors
|
CA2536954C
(en)
|
2003-08-29 |
2012-11-27 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
US8084457B2
(en)
|
2003-09-15 |
2011-12-27 |
Lead Discovery Center Gmbh |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
DK1679074T3
(da)
|
2003-10-24 |
2011-03-21 |
Santen Pharmaceutical Co Ltd |
Terapeutisk middel til keratoconjunktive forstyrrelser
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
JP2007512316A
(ja)
|
2003-11-25 |
2007-05-17 |
ファイザー・プロダクツ・インク |
アテローム性動脈硬化症の治療方法
|
CN1893952A
(zh)
|
2003-12-17 |
2007-01-10 |
辉瑞产品公司 |
用于治疗移植排斥的吡咯并[2,3-d]嘧啶化合物
|
ES2527118T3
(es)
|
2003-12-19 |
2015-01-20 |
Plexxikon Inc. |
Compuestos y procedimientos de desarrollo de moduladores de Ret
|
MXPA06007076A
(es)
|
2003-12-19 |
2006-08-31 |
Pharmacopeia Drug Discovery |
Tiadiazoles como ligandos del receptor cxc y cc-quimiocina.
|
JP4928949B2
(ja)
|
2003-12-23 |
2012-05-09 |
アステックス、セラピューティックス、リミテッド |
タンパク質キナーゼモジュレーターとしてのピラゾール誘導体
|
US20050165029A1
(en)
|
2004-01-13 |
2005-07-28 |
Ambit Biosciences Corporation |
Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
|
US20050277629A1
(en)
|
2004-03-18 |
2005-12-15 |
The Brigham And Women's Hospital, Inc. |
Methods for the treatment of synucleinopathies (Lansbury)
|
EP1730146B1
(en)
|
2004-03-30 |
2011-05-04 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of jak and other protein kinases
|
EP1750727A2
(en)
|
2004-04-23 |
2007-02-14 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
WO2005105814A1
(en)
|
2004-04-28 |
2005-11-10 |
Incyte Corporation |
Tetracyclic inhibitors of janus kinases
|
US7558717B2
(en)
|
2004-04-28 |
2009-07-07 |
Vertex Pharmaceuticals Incorporated |
Crystal structure of human JAK3 kinase domain complex and binding pockets thereof
|
BRPI0510627A
(pt)
|
2004-05-03 |
2007-10-30 |
Novartis Ag |
combinações que compreendem um agonista do receptor s1p e um inibidor da jak3 quinase
|
WO2005110410A2
(en)
|
2004-05-14 |
2005-11-24 |
Abbott Laboratories |
Kinase inhibitors as therapeutic agents
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
MXPA06014247A
(es)
|
2004-06-10 |
2007-03-12 |
Irm Llc |
Compuestos y composiciones como inhibidores de la proteina quinasa.
|
EP1760071A4
(en)
|
2004-06-23 |
2008-03-05 |
Ono Pharmaceutical Co |
COMPOUND WITH S1P RECEPTOR BINDING ABILITY AND USE THEREOF
|
EP1765819B1
(en)
|
2004-06-30 |
2014-03-12 |
Vertex Pharmaceuticals Inc. |
Azaindoles useful as inhibitors of protein kinases
|
US7138423B2
(en)
|
2004-07-20 |
2006-11-21 |
Bristol-Myers Squibb Company |
Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
|
FR2873691B1
(fr)
|
2004-07-29 |
2006-10-06 |
Sanofi Synthelabo |
Derives d'amino-piperidine, leur preparation et leur application en therapeutique
|
WO2006013114A1
(en)
|
2004-08-06 |
2006-02-09 |
Develogen Aktiengesellschaft |
Use of a timp-2 secreted protein product for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
|
WO2006022459A1
(en)
|
2004-08-23 |
2006-03-02 |
Mogam Biotechnology Institute |
Primer and probe for detection of sars coronavirus, kit comprising the primer and/or the probe, and detection method thereof
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
KR100858262B1
(ko)
|
2004-10-13 |
2008-09-11 |
에프. 호프만-라 로슈 아게 |
Cdk2 및 혈관신생에 대한 저해제로서 유용하고, 유방암,대장암, 폐암 및 전립선암의 치료용으로 유용한이중치환된 피라졸로벤조디아제핀
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
WO2006052913A1
(en)
|
2004-11-04 |
2006-05-18 |
Vertex Pharmaceuticals Incorporated |
PYRAZOLO[1,5-a]PYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
|
RU2007123675A
(ru)
|
2004-11-24 |
2008-12-27 |
Новартис АГ (CH) |
Комбинации ингибиторов jak
|
US7517870B2
(en)
|
2004-12-03 |
2009-04-14 |
Fondazione Telethon |
Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularization
|
WO2006065916A1
(en)
|
2004-12-14 |
2006-06-22 |
Alcon, Inc. |
Method of treating dry eye disorders using 13(s)-hode and its analogs
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
TW200635899A
(en)
|
2004-12-22 |
2006-10-16 |
Astrazeneca Ab |
Chemical compounds
|
JP2008528477A
(ja)
|
2005-01-20 |
2008-07-31 |
ファイザー・リミテッド |
化合物
|
CN101142218B
(zh)
|
2005-02-03 |
2013-02-06 |
沃泰克斯药物股份有限公司 |
可用作蛋白激酶抑制剂的吡咯并嘧啶
|
WO2007044050A2
(en)
|
2005-02-04 |
2007-04-19 |
Bristol-Myers Squibb Company |
1h-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
|
US20080188483A1
(en)
|
2005-03-15 |
2008-08-07 |
Irm Llc |
Compounds and Compositions as Protein Kinase Inhibitors
|
EP1874772A1
(en)
|
2005-04-05 |
2008-01-09 |
Pharmacopeia, Inc. |
Purine and imidazopyridine derivatives for immunosuppression
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
ATE540948T1
(de)
|
2005-05-20 |
2012-01-15 |
Vertex Pharma |
Pyrrolopyridine als proteinkinasehemmer
|
SG137989A1
(en)
|
2005-06-08 |
2008-01-28 |
Rigel Pharmaceuticals Inc |
Compositions and methods for inhibition of the JAK pathway
|
WO2006136823A1
(en)
|
2005-06-21 |
2006-12-28 |
Astex Therapeutics Limited |
Heterocyclic containing amines as kinase b inhibitors
|
CN102603581B
(zh)
|
2005-06-22 |
2015-06-24 |
普莱希科公司 |
作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
|
CN102127078A
(zh)
|
2005-07-14 |
2011-07-20 |
安斯泰来制药株式会社 |
Janus激酶3的杂环类抑制剂
|
FR2889662B1
(fr)
*
|
2005-08-11 |
2011-01-14 |
Galderma Res & Dev |
Emulsion de type huile-dans-eau pour application topique en dermatologie
|
US20070049591A1
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Inhibitors of MAPK/Erk Kinase
|
EP2270014A1
(en)
|
2005-09-22 |
2011-01-05 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
US8580802B2
(en)
|
2005-09-30 |
2013-11-12 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases
|
WO2007044894A2
(en)
|
2005-10-11 |
2007-04-19 |
Chembridge Research Laboratories, Inc. |
Cell-free protein expression systems and methods of use thereof
|
KR101315574B1
(ko)
|
2005-10-14 |
2013-10-08 |
스미또모 가가꾸 가부시끼가이샤 |
히드라지드 화합물 및 이의 살충 용도
|
RU2463302C2
(ru)
|
2005-10-28 |
2012-10-10 |
Астразенека Аб |
Производные 4-(3-аминопиразол)пиримидина для применения в качестве ингибиторов тирозинкиназы для лечения злокачественного новообразования
|
CN103626742B
(zh)
|
2005-11-01 |
2017-04-26 |
塔格根公司 |
激酶的联-芳基间-嘧啶抑制剂
|
WO2007062459A1
(en)
|
2005-11-29 |
2007-06-07 |
Cytopia Research Pty Ltd |
Selective kinase inhibitors based on pyridine scaffold
|
ES2612196T3
(es)
|
2005-12-13 |
2017-05-12 |
Incyte Holdings Corporation |
Pirrolo[2,3-b]piridinas y pirrolo[2,3-b]pirimidinas sustituidas con heteroarilo como inhibidores de quinasas Janus
|
US20130137681A1
(en)
|
2005-12-13 |
2013-05-30 |
Incyte Corporation |
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
|
WO2007076423A2
(en)
|
2005-12-22 |
2007-07-05 |
Smithkline Beecham Corporation |
INHIBITORS OF Akt ACTIVITY
|
SI1962830T1
(sl)
|
2005-12-23 |
2013-07-31 |
Glaxosmithkline Llc |
Azaindolni inhibitorji kinaz Aurora
|
CA2636189A1
(en)
|
2006-01-17 |
2007-07-26 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of janus kinases
|
CA2635899A1
(en)
|
2006-01-19 |
2007-07-26 |
Osi Pharmaceuticals, Inc. |
Fused heterobicyclic kinase inhibitors
|
WO2007090141A2
(en)
|
2006-02-01 |
2007-08-09 |
Smithkline Beecham Corporation |
Pyrrolo [2, 3, b] pyridine derivatives useful as raf kinase inhibitors
|
US7745477B2
(en)
|
2006-02-07 |
2010-06-29 |
Hoffman-La Roche Inc. |
Heteroaryl and benzyl amide compounds
|
CA2644368A1
(en)
|
2006-03-10 |
2007-09-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
|
FR2898498B1
(fr)
*
|
2006-03-15 |
2008-11-28 |
Galderma Sa |
Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
|
AU2007236707C1
(en)
|
2006-04-03 |
2012-05-24 |
Astellas Pharma Inc. |
Hetero compound
|
EP2001884A1
(en)
|
2006-04-05 |
2008-12-17 |
Vertex Pharmaceuticals, Inc. |
Deazapurines useful as inhibitors of janus kinases
|
CA2647448A1
(en)
|
2006-04-12 |
2007-10-18 |
Pfizer Limited |
Pyrrolidine derivatives as modulators of chemokine ccr5 receptors
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
US20080051427A1
(en)
|
2006-05-18 |
2008-02-28 |
Fritz Schuckler |
Pharmaceutical Compositions and Methods of Using Same
|
US7691811B2
(en)
|
2006-05-25 |
2010-04-06 |
Bodor Nicholas S |
Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
|
TWI398252B
(zh)
|
2006-05-26 |
2013-06-11 |
Novartis Ag |
吡咯并嘧啶化合物及其用途
|
WO2008011560A2
(en)
|
2006-07-20 |
2008-01-24 |
Mehmet Kahraman |
Benzothiophene inhibitors of rho kinase
|
US8715700B2
(en)
*
|
2006-07-21 |
2014-05-06 |
Dow Pharmaceutical Sciences, Inc. |
Alpha hydroxy acid sustained release formulation
|
WO2008013622A2
(en)
|
2006-07-27 |
2008-01-31 |
E. I. Du Pont De Nemours And Company |
Fungicidal azocyclic amides
|
US8492378B2
(en)
|
2006-08-03 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
GSK-3β inhibitor
|
JP5252404B2
(ja)
|
2006-08-16 |
2013-07-31 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ピラジン化合物、その使用及び調製方法
|
AR062677A1
(es)
|
2006-09-08 |
2008-11-26 |
Novartis Ag |
Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
|
WO2008035376A2
(en)
|
2006-09-19 |
2008-03-27 |
Council Of Scientific & Industrial Research |
A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof
|
TW200837064A
(en)
|
2006-10-04 |
2008-09-16 |
Pharmacopeia Inc |
8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression
|
US7919490B2
(en)
|
2006-10-04 |
2011-04-05 |
Wyeth Llc |
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
|
US20120225057A1
(en)
|
2006-10-11 |
2012-09-06 |
Deciphera Pharmaceuticals, Llc |
Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases
|
JP5357763B2
(ja)
|
2006-11-06 |
2013-12-04 |
トレロ ファーマシューティカルズ, インコーポレイテッド |
イミダゾ[1,2−b]ピリダジン誘導体およびピラゾロ[1,5−a]ピリダジン誘導体およびプロテインキナーゼインヒビターとしてのこれらの使用
|
US20080119496A1
(en)
|
2006-11-16 |
2008-05-22 |
Pharmacopeia Drug Discovery, Inc. |
7-Substituted Purine Derivatives for Immunosuppression
|
SI3034075T1
(sl)
|
2006-11-22 |
2018-12-31 |
Incyte Holdings Corporation |
Imidazotriazini in imidazopirimidini kot inhibitorji kinaze
|
WO2008067119A2
(en)
|
2006-11-27 |
2008-06-05 |
Smithkline Beecham Corporation |
Novel compounds
|
CA2672616A1
(en)
|
2006-12-15 |
2008-06-26 |
Abbott Laboratories |
Novel oxadiazole compounds
|
AU2007338792B2
(en)
|
2006-12-20 |
2012-05-31 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
AU2007338793B2
(en)
|
2006-12-20 |
2012-05-03 |
Amgen Inc. |
Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer
|
BRPI0720434A2
(pt)
|
2006-12-22 |
2014-01-07 |
Sigma Tau Ind Farmaceuti |
Gel útil para liberação de fármacos oftálmicos
|
EP2121692B1
(en)
|
2006-12-22 |
2013-04-10 |
Incyte Corporation |
Substituted heterocycles as janus kinase inhibitors
|
KR20080062876A
(ko)
|
2006-12-29 |
2008-07-03 |
주식회사 대웅제약 |
신규한 항진균성 트리아졸 유도체
|
WO2008082839A2
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
WO2008082840A1
(en)
|
2006-12-29 |
2008-07-10 |
Abbott Laboratories |
Pim kinase inhibitors as cancer chemotherapeutics
|
AU2008221263B2
(en)
|
2007-03-01 |
2012-02-23 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
AU2008237507B2
(en)
|
2007-04-03 |
2014-03-20 |
Array Biopharma Inc. |
Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
|
GB0709031D0
(en)
|
2007-05-10 |
2007-06-20 |
Sareum Ltd |
Pharmaceutical compounds
|
EP2155689B1
(en)
|
2007-05-31 |
2015-07-08 |
Boehringer Ingelheim International GmbH |
Ccr2 receptor antagonists and uses thereof
|
GB0710528D0
(en)
|
2007-06-01 |
2007-07-11 |
Glaxo Group Ltd |
Novel compounds
|
MX342814B
(es)
|
2007-06-13 |
2016-10-13 |
Incyte Holdings Corp |
Sales de inhibidor de janus cinasa (r)-3-(4-7h-pirrolo[2,3-d]pirim idin-4-il)-1h-pirazol-1-il)-3-ciclopentilpropanitrilo.
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
AU2008273804B2
(en)
|
2007-07-11 |
2014-07-10 |
Pfizer Inc. |
Pharmaceutical compositions and methods of treating dry eye disorders
|
AU2008281543A1
(en)
|
2007-08-01 |
2009-02-05 |
Pfizer Inc. |
Pyrazole compounds and their use as Raf inhibitors
|
WO2009049028A1
(en)
|
2007-10-09 |
2009-04-16 |
Targegen Inc. |
Pyrrolopyrimidine compounds and their use as janus kinase modulators
|
US20110263664A1
(en)
|
2007-11-15 |
2011-10-27 |
Musc Foundation For Research Development |
Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer
|
CN101910152B
(zh)
|
2007-11-16 |
2014-08-06 |
因塞特公司 |
作为janus激酶抑制剂的4-吡唑基-n-芳基嘧啶-2-胺和4-吡唑基-n-杂芳基嘧啶-2-胺
|
GB0723815D0
(en)
|
2007-12-05 |
2008-01-16 |
Glaxo Group Ltd |
Compounds
|
PL3133080T3
(pl)
|
2008-01-18 |
2018-12-31 |
Inst Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Nowe cytostatyczne nukleozydy 7-deazapurynowe
|
BRPI0905952A2
(pt)
|
2008-02-04 |
2015-06-30 |
Mercury Therapeutics |
Composto e sais do mesmo e compição farmacêutica
|
UY31679A1
(es)
|
2008-03-03 |
2009-09-30 |
|
Inhibidores de cinasa pim y metodos para su uso
|
MX2010010012A
(es)
|
2008-03-11 |
2010-10-20 |
Incyte Corp |
Derivados de azetidina y ciclobutano como inhibidores de jak.
|
EA201001456A1
(ru)
|
2008-03-21 |
2011-06-30 |
Новартис Аг |
Новые гетероциклические соединения и их применение
|
US20110212157A1
(en)
*
|
2008-06-26 |
2011-09-01 |
Anterios, Inc. |
Dermal delivery
|
UY31952A
(es)
|
2008-07-02 |
2010-01-29 |
Astrazeneca Ab |
5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
|
FR2933409B1
(fr)
|
2008-07-03 |
2010-08-27 |
Centre Nat Rech Scient |
NOUVEAUX PYRROLO °2,3-a! CARBAZOLES ET LEUR UTILISATION COMME INHIBITEURS DES KINASES PIM
|
WO2010022081A1
(en)
|
2008-08-19 |
2010-02-25 |
Array Biopharma Inc. |
Triazolopyridine compounds as pim kinase inhibitors
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
BRPI0917459B1
(pt)
|
2008-08-20 |
2017-09-12 |
Zoetis Services Llc |
N-methyl-1- [trans-4- [methyl (7h-pyrrol [2,3-d] pyridol [2,3-d] pyrimidine compounds, use of these in therapy and crystalline a form of n-methyl- pyrimidin-4-yl) amino] cyclohexyl} methanosulphonamide
|
WO2010026121A1
(en)
|
2008-09-02 |
2010-03-11 |
Novartis Ag |
Bicyclic kinase inhibitors
|
EP2344473B1
(en)
|
2008-09-02 |
2014-04-16 |
Novartis AG |
Heterocyclic pim-kinase inhibitors
|
PL2344474T3
(pl)
|
2008-09-02 |
2016-03-31 |
Novartis Ag |
Pochodne pikolinamidu jako inhibitory kinaz
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
AU2009304508A1
(en)
|
2008-10-17 |
2010-04-22 |
Merck Frosst Canada Ltd. |
Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
JOP20190230A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
EP2210890A1
(en)
|
2009-01-19 |
2010-07-28 |
Almirall, S.A. |
Oxadiazole derivatives as S1P1 receptor agonists
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
KR20120030447A
(ko)
|
2009-05-22 |
2012-03-28 |
인사이트 코포레이션 |
Jak 저해물질로서 3-[4-(7h-피롤로[2,3-d]피리미딘-4-일)-1h-피라졸-1-일]옥탄- 또는 헵탄-니트릴
|
CA2762174C
(en)
|
2009-05-22 |
2018-02-20 |
Incyte Corporation |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
CN101958119B
(zh)
|
2009-07-16 |
2012-02-29 |
中兴通讯股份有限公司 |
一种改进的离散余弦变换域音频丢帧补偿器和补偿方法
|
WO2011025685A1
(en)
|
2009-08-24 |
2011-03-03 |
Merck Sharp & Dohme Corp. |
Jak inhibition blocks rna interference associated toxicities
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
EP2475659B1
(en)
|
2009-09-08 |
2015-10-28 |
F.Hoffmann-La Roche Ag |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
EP2305660A1
(en)
|
2009-09-25 |
2011-04-06 |
Almirall, S.A. |
New thiadiazole derivatives
|
EA021478B1
(ru)
|
2009-10-09 |
2015-06-30 |
Инсайт Корпорейшн |
ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
|
KR20120102601A
(ko)
|
2009-10-20 |
2012-09-18 |
셀좀 리미티드 |
Jak 저해제로서의 헤테로시클릴 피라졸로피리미딘 유사체
|
EP2332917B1
(en)
|
2009-11-11 |
2012-08-01 |
Sygnis Bioscience GmbH & Co. KG |
Compounds for PIM kinase inhibition and for treating malignancy
|
CN102740888B
(zh)
|
2009-11-24 |
2016-10-12 |
奥尔德生物制药公司 |
Il-6抗体及其用途
|
WO2011069141A2
(en)
|
2009-12-04 |
2011-06-09 |
Board Of Regents, The University Of Texas System |
Interferon therapies in combination with blockade of stat3 activation
|
AR079984A1
(es)
|
2010-01-12 |
2012-03-07 |
Hoffmann La Roche |
Compuestos heterociclicos triciclicos, composiciones y su uso en el tratamiento de enfermedades mediadas por la inhibicion de jak1
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
WO2011103423A1
(en)
|
2010-02-18 |
2011-08-25 |
Incyte Corporation |
Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
|
RS60680B1
(sr)
|
2010-03-10 |
2020-09-30 |
Incyte Holdings Corp |
Piperidin-4-il azetidin derivati kao inhibitori jak1
|
WO2011130146A1
(en)
|
2010-04-14 |
2011-10-20 |
Array Biopharma Inc. |
5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
|
EP2390252A1
(en)
|
2010-05-19 |
2011-11-30 |
Almirall, S.A. |
New pyrazole derivatives
|
SG10201503983QA
(en)
|
2010-05-21 |
2015-06-29 |
Incyte Corp |
Topical Formulation for a JAK Inhibitor
|
US8637529B2
(en)
|
2010-06-11 |
2014-01-28 |
AbbYie Inc. |
Pyrazolo[3,4-d]pyrimidine compounds
|
US9351943B2
(en)
|
2010-07-01 |
2016-05-31 |
Matthew T. McLeay |
Anti-fibroblastic fluorochemical emulsion therapies
|
WO2012045020A1
(en)
|
2010-09-30 |
2012-04-05 |
Portola Pharmaceuticals, Inc. |
Combinations of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine
|
EP2640725B1
(en)
|
2010-11-19 |
2015-01-07 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
TW201249845A
(en)
|
2010-11-19 |
2012-12-16 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
WO2012071612A1
(en)
|
2010-12-03 |
2012-06-07 |
Ym Biosciences Australia Pty Ltd |
Treatment of jak2-mediated conditions
|
MX357939B
(es)
|
2011-02-18 |
2018-07-31 |
Novartis Pharma Ag |
Terapia de combinacion de inhibidor de objetivo de rapamicina en mamifero/janus cinasa (mtor/jak).
|
MY165963A
(en)
|
2011-06-20 |
2018-05-18 |
Incyte Holdings Corp |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
WO2013023119A1
(en)
|
2011-08-10 |
2013-02-14 |
Novartis Pharma Ag |
JAK P13K/mTOR COMBINATION THERAPY
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
AR091079A1
(es)
|
2012-05-18 |
2014-12-30 |
Incyte Corp |
Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak
|
US10155987B2
(en)
|
2012-06-12 |
2018-12-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of predicting resistance to JAK inhibitor therapy
|
WO2014036016A1
(en)
|
2012-08-31 |
2014-03-06 |
Principia Biopharma Inc. |
Benzimidazole derivatives as itk inhibitors
|
US9181271B2
(en)
|
2012-11-01 |
2015-11-10 |
Incyte Holdings Corporation |
Tricyclic fused thiophene derivatives as JAK inhibitors
|
RS62329B1
(sr)
|
2012-11-15 |
2021-10-29 |
Incyte Holdings Corp |
Dozni oblici ruksolitiniba sa produženim vremenom oslobađanja
|
ES2900492T3
(es)
|
2013-03-06 |
2022-03-17 |
Incyte Holdings Corp |
Procesos y productos intermedios para elaborar un inhibidor de JAK
|
PT3231801T
(pt)
|
2013-05-17 |
2019-05-24 |
Incyte Corp |
Sal de bipirazole como inibidor da jak
|
EA201690357A1
(ru)
|
2013-08-07 |
2016-07-29 |
Инсайт Корпорейшн |
Лекарственные формы с замедленным высвобождением для ингибитора jak1
|
AU2014309017A1
(en)
|
2013-08-20 |
2016-03-10 |
Incyte Corporation |
Survival benefit in patients with solid tumors with elevated C-reactive protein levels
|
PT3110409T
(pt)
|
2014-02-28 |
2018-11-07 |
Incyte Corp |
Inibidores de jak1 para o tratamento de síndromes mielodisplásicas
|
CA2945151C
(en)
|
2014-04-08 |
2022-08-02 |
Incyte Corporation |
Treatment of b-cell malignancies by a combination jak and pi3k inhibitors
|
EP3137471A1
(en)
|
2014-04-30 |
2017-03-08 |
Incyte Corporation |
Processes of preparing a jak1 inhibitor and new forms thereto
|
EP4233870A3
(en)
|
2014-05-28 |
2024-01-24 |
Onco Tracker, Inc. |
Anti-cancer effects of jak2 inhibitors in combination with thalidomide derivatives and glucocorticoids
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|